Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Alset E Home International Stockholders Equity [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2020			$ 8,570	$ 102,729,944	$ 2,143,338	$ (44,910,297)	$ 59,971,555	$ 38,023,260	$ 97,994,815
Beginning balance, shares at Dec. 31, 2020			8,570,000
Beneficial Conversion Feature Intrinsic Value, Net				50,770,192			50,770,192		50,770,192
Change in Non-Controlling Interest				76,412	(39,067)		37,345	(37,345)
Change in Unrealized Loss on Investment					(1,135)		(1,135)	(852)	(1,987)
Foreign Currency Translations					(1,010,527)		(1,010,527)	(758,913)	(1,769,440)
Net Loss						(6,238,449)	(6,238,449)	(3,569,112)	(9,807,561)
Issuance of Stock for Services			$ 10	60,890			60,900		60,900
Issuance of Stock for Services, shares			10,000
Transactions under Common Control				(57,190,499)			(57,190,499)		(57,190,499)
Sale of Vivacitas to Related Party				2,279,872			2,279,872		2,279,872
Purchase Stock of True Partner from Related Party				3,274,060			3,274,060		3,274,060
Subsidiary’s Issuance of Stock				46,099			46,099	34,677	80,776
Proceeds from Selling Subsidiary Equity				142,675.00			142,675	107,325	250,000
Distribution to Non-Controlling Shareholders								(82,250)	(82,250)
Ending balance, value at Mar. 31, 2021			$ 8,580	102,189,645	1,092,609	(51,148,746)	52,142,088	33,716,790	85,858,878
Ending balance, shares at Mar. 31, 2021			8,580,000
Beginning balance, value at Dec. 31, 2020			$ 8,570	102,729,944	2,143,338	(44,910,297)	59,971,555	38,023,260	97,994,815
Beginning balance, shares at Dec. 31, 2020			8,570,000
Net Loss									(84,696,885)
Ending balance, value at Jun. 30, 2021			$ 28,265	204,762,770	(40,823)	(117,799,610)	86,950,602	28,114,184	115,064,786
Ending balance, shares at Jun. 30, 2021			28,265,289
Beginning balance, value at Mar. 31, 2021			$ 8,580	102,189,645	1,092,609	(51,148,746)	52,142,088	33,716,790	85,858,878
Beginning balance, shares at Mar. 31, 2021			8,580,000
Change in Non-Controlling Interest				(2,885,117)	(343,225)		(3,228,342)	3,228,342
Change in Unrealized Loss on Investment					(25,663)		(25,663)	(10,259)	(35,922)
Foreign Currency Translations					(764,544)		(764,544)	(305,647)	(1,070,191)
Net Loss						(66,650,864)	(66,650,864)	(8,238,460)	(74,889,324)
Issuance of Common Stock			$ 8,389	39,260,191			39,268,580	0	39,268,580
Issuance of Common Stock, shares			8,389,324
Proceeds from Selling Subsidiary Equity				21,432			21,432	8,568	30,000
Change Common stock to Series A Preferred Stock	$ 6		$ (6,380)	6,374				0
Change Common stock to Series A Preferred Stock, shares	6,380		(6,380,000)
Issuance of Series B Preferred Stock		$ 2		12,999,998			13,000,000	0	13,000,000
Issuance of Series B Preferred Stock, shares		2,132
Convert Preferred Stock Series A and B to Common	$ (6)	$ (2)	$ 8,512	(8,503)				0
Convert Preferred Stock Series A and B to Common, shares	(6,380)	(2,132)	8,512,000
Convertible Note to Stock			$ 9,164	51,217,402			51,226,566		51,226,566
Convertible Note to Stock, shares			9,163,965
Subsidiary’s Issuance of Stock				1,961,349			1,961,349	784,100	2,745,449
Distribution to Non-Controlling Shareholders								(1,069,250)	(1,069,250)
Ending balance, value at Jun. 30, 2021			$ 28,265	204,762,770	(40,823)	(117,799,610)	86,950,602	28,114,184	115,064,786
Ending balance, shares at Jun. 30, 2021			28,265,289
Beginning balance, value at Dec. 31, 2021			$ 87,368	296,181,977	341,646	(148,233,473)	148,377,518	21,912,268	170,289,786
Beginning balance, shares at Dec. 31, 2021			87,368,446
Issuance of Stock by Exercising Warrants			$ 15,820	(11,925)			3,895		3,895
Issuance of Stock by Exercising Warrants, shares			15,819,452
Convert Related Party Note to Common Stock			$ 10,000	6,203,000			6,213,000		6,213,000
Convert Related Party Note to Common Stock, shares			10,000,000
Deconsolidate Alset Capital Acquisition				17,160,800			17,160,800	2,227,744	19,388,544
Gain from Purchase of DSS Stock				737,572			737,572		737,572
Beneficial Conversion Feature Intrinsic Value, Net				450,000			450,000		450,000
Change in Non-Controlling Interest				(316,459)	459,069		142,610	(142,610)
Change in Unrealized Loss on Investment					(7,027)		(7,027)	(2,096)	(9,123)
Foreign Currency Translations					(499,967)		(499,967)	(149,173)	(649,140)
Net Loss						(6,467,286)	(6,467,286)	(1,463,167)	(7,930,453)
Ending balance, value at Mar. 31, 2022			$ 113,188	320,404,965	293,721	(154,700,759)	166,111,115	22,382,966	188,494,081
Ending balance, shares at Mar. 31, 2022			113,187,898
Beginning balance, value at Dec. 31, 2021			$ 87,368	296,181,977	341,646	(148,233,473)	148,377,518	21,912,268	170,289,786
Beginning balance, shares at Dec. 31, 2021			87,368,446
Net Loss									(17,913,314)
Distribution to Non-Controlling Shareholders									(1,151,500)
Ending balance, value at Jun. 30, 2022			$ 148,507	322,302,515	558,045	(163,688,118)	159,320,949	12,844,123	172,165,072
Ending balance, shares at Jun. 30, 2022			148,507,188
Beginning balance, value at Mar. 31, 2022			$ 113,188	320,404,965	293,721	(154,700,759)	166,111,115	22,382,966	188,494,081
Beginning balance, shares at Mar. 31, 2022			113,187,898
Change in Non-Controlling Interest				4,557,454	3,266,996		7,824,450	(7,824,450)
Change in Unrealized Loss on Investment					(505)		(505)	(86)	(591)
Foreign Currency Translations					(3,002,167)		(3,002,167)	(512,428)	(3,514,595)
Net Loss						(8,987,359)	(8,987,359)	(995,502)	(9,982,861)
Issuance of Common Stock			$ 35,319	(35,319)
Issuance of Common Stock, shares			35,319,290
Change in Valuation on Investment				(2,624,585)			(2,624,585)	(206,377)	(2,830,962)
Ending balance, value at Jun. 30, 2022			$ 148,507	$ 322,302,515	$ 558,045	$ (163,688,118)	$ 159,320,949	$ 12,844,123	$ 172,165,072
Ending balance, shares at Jun. 30, 2022			148,507,188